Caricamento...

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China

The study aims to examine the treatment effect and adverse reactions of patients with newly diagnosed MM receiving different bortezomib-based regimens. This was a retrospective study of patients with newly diagnosed MM and who were treated with bortezomib-based combined chemotherapy at the Departmen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Yao, Rongxin, Hu, Xudong, Zhou, Shuping, Zhang, Qianying, Huang, He, Sun, Ni, Guo, Wenjian, Yu, Kang, Lin, Ying
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775427/
https://ncbi.nlm.nih.gov/pubmed/31574817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017147
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !